In response to the Heparin Contamination Crisis, our group partnered with several others to begin bioengineering Heparin from bacteria. Together with Dr. Liu of UNC, we successfully created a synthetic Heparin using enzymatic synthesis. Today, Dr. Linhardt is internationally known for his research on the study of bioactive carbohydrates, particularly the complex polysaccharide heparin.

Back to top